Chapter 176

Hans nodded. "The latest CAR-T cell immunotherapy developed by Professor Perez's team is specifically designed for this type of relapsed leukemia with multi-organ failure in patients who can't tolerate chemotherapy. The clinical data so far show an extremely high remission rate. However, this treat...

Login and Continue Reading